HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Our innovative portfolio — from 𝐇𝐲𝐚𝐥𝐮𝐫𝐨𝐧𝐢𝐜 𝐀𝐜𝐢𝐝 to 𝐏𝐨𝐥𝐲𝐧𝐮𝐜𝐥𝐞𝐨𝐭𝐢𝐝𝐞𝐬, 𝐍𝐞𝐮𝐫𝐨𝐦𝐨𝐝𝐮𝐥𝐚𝐭𝐨𝐫𝐬, and 𝐇𝐮𝐦𝐚𝐧 𝐑𝐞𝐜𝐨𝐦𝐛𝐢𝐧𝐚𝐧𝐭 𝐂𝐨𝐥𝐥𝐚𝐠𝐞𝐧 — drew significant interest.
Our products were highlighted in 𝐬𝐲𝐦𝐩𝐨𝐬𝐢𝐚, on our clients’ booths, and in expert discussions. It was inspiring to see industry leaders recognize the quality and innovation behind HTL Inside.
Thank you to everyone who came to our booth and engaged discussions with our team!
Feel the difference with HTL Inside.
We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.